Brief: Cartesian Therapeutics Reports Q3 2024 Financial Results And Provides Business Update
07/11/2024 12:43
Nov 7 (Reuters) - Cartesian Therapeutics Inc RNAC.O :
* CARTESIAN THERAPEUTICS REPORTS THIRD QUARTER 2024
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CARTESIAN THERAPEUTICS INC: QTRLY BASIC NET LOSS PER SHARE
$1.13
Source text: ID:nGNX3X6byq
Further company coverage: RNAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview